SF
Stephen F. Badylak
Chairman, Scientific & Clinical Advisory Board
Harvard Apparatus Regenerative TechnologyTherapeutic Areas
Harvard Apparatus Regenerative Technology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cellspan Esophageal Implant (CEI) | Long-Gap Esophageal Atresia | Phase 1 |
Leadership Team at Harvard Apparatus Regenerative Technology
JH
Jerry He
Chief Executive Officer & Chairman of the Board
HY
Hong Yu
President
JD
Joseph Damasio, Jr.
Chief Financial Officer
WF
William Fodor
Chief Scientific Officer
DG
David Green
Founder & Director
JJ
Jason Jing Chen
Vice Chairman of the Board
TL
Ting Li
Director